E-LIB Suche - Ergebnisse für: McClain, J. Bruce - Sprache EN

Search for persons X

Sorted by: Relevance

Sorted by: Year

1

Safety, Pharmacokinetics, and Neutralizing Activity of SYN0..:

McClain, J. Bruce ; Chuang, Ariel ; Moore, Susan M..
Clinical Pharmacology in Drug Development. 10 (2021) 7 - p. 807-817 , 2021

Link: https://doi.org/10.1002/..

2

Rabies virus neutralizing activity, pharmacokinetics, and s..:

McClain, J. Bruce ; Chuang, Ariel ; Reid, Caroline..
Vaccine. 39 (2021) 40 - p. 5822-5830 , 2021

Link: https://doi.org/10.1016/..

3

Cytomegalovirus infection is a risk factor for tuberculosis..:

Müller, Julius ; Tanner, Rachel ; Matsumiya, Magali...
JCI Insight. 4 (2019) 23 - p. , 2019

Link: https://doi.org/10.1172/..

4

Safety and immunogenicity of the novel H4:IC31 tuberculosis..:

Norrby, Maria ; Vesikari, Timo ; Lindqvist, Lars...
Vaccine. 35 (2017) 12 - p. 1652-1661 , 2017

Link: https://doi.org/10.1016/..

5

Adenovirus type 35-vectored tuberculosis vaccine has an acc..:

Walsh, Douglas S. ; Owira, Victorine ; Polhemus, Mark...
Vaccine. 34 (2016) 21 - p. 2430-2436 , 2016

Link: https://doi.org/10.1016/..

6

Correction: Corrigendum: T-cell activation is an immune cor..:

Fletcher, Helen A. ; Snowden, Margaret A. ; Landry, Bernard...
Nature Communications. 7 (2016) 1 - p. , 2016

Link: https://doi.org/10.1038/..

7

Safety and Immunogenicity of the Recombinant BCG Vaccine AE..:

Hoft, Daniel F. ; Blazevic, Azra ; Selimovic, Asmir...
EBioMedicine. 7 (2016) - p. 278-286 , 2016

Link: https://doi.org/10.1016/..

8

T-cell activation is an immune correlate of risk in BCG vac..:

Fletcher, Helen A. ; Snowden, Margaret A. ; Landry, Bernard...
Nature Communications. 7 (2016) 1 - p. , 2016

Link: https://doi.org/10.1038/..

9

The safety and immunogenicity of an adenovirus type 35-vect..:

Churchyard, Gavin John ; Snowden, Margaret Ann ; Hokey, David...
Vaccine. 33 (2015) 15 - p. 1890-1896 , 2015

Link: https://doi.org/10.1016/..

10

The tuberculosis vaccine H4:IC31 is safe and induces a pers..:

Geldenhuys, Hennie ; Mearns, Helen ; Miles, David J.C....
Vaccine. 33 (2015) 30 - p. 3592-3599 , 2015

Link: https://doi.org/10.1016/..

11

First-in-human trial of the post-exposure tuberculosis vacc..:

Luabeya, Angelique Kany Kany ; Kagina, Benjamin M.N. ; Tameris, Michele D....
Vaccine. 33 (2015) 33 - p. 4130-4140 , 2015

Link: https://doi.org/10.1016/..

12

The novel tuberculosis vaccine, AERAS-402, is safe in healt..:

Kagina, Benjamin M.N. ; Tameris, Michele D. ; Geldenhuys, Hennie...
Vaccine. 32 (2014) 45 - p. 5908-5917 , 2014

Link: https://doi.org/10.1016/..

13

Safety and efficacy of MVA85A, a new tuberculosis vaccine, ..:

Tameris, Michele D ; Hatherill, Mark ; Landry, Bernard S...
The Lancet. 381 (2013) 9871 - p. 1021-1028 , 2013

Link: https://doi.org/10.1016/..

14

Lessons learnt from the first efficacy trial of a new infan..:

Tameris, Michele ; McShane, Helen ; McClain, J. Bruce...
Tuberculosis. 93 (2013) 2 - p. 143-149 , 2013

Link: https://doi.org/10.1016/..

15

A recombinant adenovirus expressing immunodominant TB antig..:

Hoft, Daniel F. ; Blazevic, Azra ; Stanley, Jaime...
Vaccine. 30 (2012) 12 - p. 2098-2108 , 2012

Link: https://doi.org/10.1016/..

1-15